Severe toxicity following synthetic cannabinoid ingestion

Clinical Toxicology

Volumn 49, Issue 8, 2011, Pages 760-764

  Lapoint, J ^a,b,c   James, L P ^d   Moran, C L ^e   Nelson, L S ^a,b,c   Hoffman, R S ^a,b,c   Moran, J H ^f,g  

^a NEW YORK CITY POISON CONTROL CENTER   (United States)

^b BELLEVUE HOSPITAL CENTER   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e Arkansas State Crime Laboratory   (United States)

^f ARKANSAS DEPARTMENT OF HEALTH   (United States)

^g UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

CNS Psychological Heart; JWH 018; Synthetic Cannabinoids

Indexed keywords

3 (1 NAPHTHOYL) 1 PENTYLINDOLE; CANNABINOID; LORAZEPAM; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG;

ADULT; AGITATION; ALCOHOL BLOOD LEVEL; ARTICLE; CARDIOVERSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG SCREENING; ELECTROENCEPHALOGRAM; EMERGENCY WARD; GRAND MAL SEIZURE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS FRAGMENTOGRAPHY; RECURRENT DISEASE; SINUS TACHYCARDIA; SUPRAVENTRICULAR TACHYCARDIA; TANDEM MASS SPECTROMETRY; URINALYSIS; VITAL SIGN;

CANNABINOIDS; ETHANOL; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INDOLES; MALE; MIDDLE AGED; NAPHTHALENES; SEIZURES; SEVERITY OF ILLNESS INDEX; TACHYCARDIA, SUPRAVENTRICULAR; TREATMENT OUTCOME;

CANNABIS SATIVA;

EID: 80053638478     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2011.609822     Document Type: Article

References (36)

1. EMCDDA. Understanding the ' Spice ' phenomenon. European Monitoring Centre for Drugs and Drug Addiction EMCDDA 2009 Thematic paper ed: Offi ce for Offi cial Publications of the European Communities; 2009: 1-25.
2. Dresen S, Ferreiros N, Putz M, Westphal F, Zimmermann R, Auwarter V. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. J Mass Spectrom 2010; 45:1186-94.
3. Uchiyama N, Kikura-Hanajiri R, Kawahara N, Haishima Y, Goda Y. Identifi cation of a cannabinoid analog as a new type of designer drug in a herbal product. Chem Pharm Bull 2009; 57:439-441.
4. Hudson S, Ramsey J, King L, Timbers S, Maynard S, Dargan Pl, Wood DM. Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products. J Anal Toxicol chem. 2010; 34:252-260.
5. Iversen LL. The Science of Marijuana Vol 2. 2nd ed. New York: Oxford University Press, Inc.; 2008.
6. -21 Code of Federal Regulations: Part 1308, Schedules of Controlled Substances: Temporary Placement of Five Synthetic Cannabinoids Into Schedule I Vol 75, 2010: 71635-71638.
7. Huffman JW. Cannabimimetic indoles, pyrroles, and indenes: Structure-activity relationships and receptor interactions. In: Reggio PH, ed. The Cannabinoid Receptors, The Receptors. Vol 1: Humana Press; New York, NY 10013 2009: 49-94.
8. Huffman JW, Padgett LW, Isherwood ML, Wiley JL, Martin BR. 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: New high affi nity ligands for the cannabinoid CB1 and CB2 receptors. Bioorg Med Chem Lett 2006; 16:5432-5435. (Pubitemid 44332197)
9. Wiley JL, Compton DR, Dai D, Lainton JA, Phillips M, Huffman JW, Martin BR. Structure-activity relationships of indole- and pyrrolederived cannabinoids. J Pharmacol Exp Ther 1998; 285:995-1004. (Pubitemid 28277896)
10. Showalter VM, Compton DR, Martin BR, Abood ME. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): Identifi cation of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 1996; 278: 89-999.
11. Compton DR, Gold LH, Ward SJ, Balster RL, Martin BR. Aminoalkylindole analogs: Cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol. J Pharmacol Exp Ther 1992; 263:1118-1126. (Pubitemid 23157189)
12. Compton DR, Johnson MR, Melvin LS, Martin BR. Pharmacological profi le of a series of bicyclic cannabinoid analogs: Classifi cation as cannabimimetic agents. J Pharmacol Exp Ther 1992; 260: 201-209.
13. Compton DR, Rice KC, De Costa BR, Razdan RK, Melvin LS, Johnson MR, Martin BR. Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 1993; 265:218-226. (Pubitemid 23320964)
14. Bell MR, D'Ambra TE, Kumar V, Eissenstat JL Jr., WEtzel JR, Rosi D, Phillon RE, Daum SJ, Hlasta DJ. Antinociceptive (aminoalkyl)indoles. J Med Chem 1991; 34:1099-1110.
15. Eissenstat MA, Bell MR, D'Ambra TE, Alexander EJ, Daum SJ, Ackerman JH, Gruett MD, Kumar V, Estep KG, Olefi rwicz EM. Aminoalkylindoles: Structure-activity relationships of novel cannabinoid mimetics. J Med Chem 1995; 38:3094-3105.
16. Vearrier D, Osterhoudt KC. A teenager with agitation: Higher than she should have climbed. Pediatr Emerg Care 2010; 26:462-465.
17. Muller H, Sperling W, Kohrmann M, Huttner HB, Kornhuber J, Maler JM. The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophr Res. 2010; 118:309-310.
18. Every-Palmer S. Warning: Legal synthetic cannabinoid-receptor agonists such as JWH-018 may precipitate psychosis in vulnerable individuals. Addiction 2010; 105:1859-1860.
19. Schneir AB, Cullen J, Ly BT. "Spice" Girls: Synthetic Cannabinoid Intoxication. J Emerg Med2011; 40:296-9
20. Zimmermann US, Winkelmann PR, Pilhatsch M, Nees JA, Spanagel R, Schulz K. Withdrawal phenomena and dependence syndrome after the consumption of "spice gold". Dtsch Arztebl Int 2009; 106:464-467.
21. Gay M. Synthetic Marijuana Spurs State Bans. The New York Times July 10, 2010.
22. Fisher WG. Inhaled incense "K2" may cause heart damage. Musings in the life of an internist, cardioloist and cardiac electrophysiologist Vol 2010. August 15.ed. Evanston, IL, http://drwes.blogspot.com/ 2010/08/inhaled-incense-k2-may-cause-heart.html? 2010.
23. Sobolevsky T, Prasolov I, Rodchenkov G. Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Sci Int; 2010; 200:141-147.
24. Atwood BK, Mackie K. CB2: A cannabinoid receptor with an identity crisis. Br J Pharmacol 2010; 160:467-479.
25. Nyiri G, Cserep C, Szabadits E, Mackie K, Freund TF. CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons. Neuroscience 2005; 136:811-822. (Pubitemid 41774726)
26. Tilelli JA, Spack LD. Marijuana intoxication presenting as seizure- comment. Pediatr Emerg Care 2006; 22:141. (Pubitemid 43361767)
27. Bonkowsky JL, Sarco D, Pomeroy SL. Ataxia and shaking in a 2-yearold girl: Acute marijuana intoxication presenting as seizure. Pediatr Emerg Care 2005; 21:527-528. (Pubitemid 41193234)
28. Wallace MJ, Martin BR, DeLorenzo RJ. Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur J Pharmacol 2002; 452:295-301. (Pubitemid 35279432)
29. Jones RT. Cardiovascular system effects of marijuana. J Clin Pharmacol 2002; 42(11 Suppl):58S-63S. (Pubitemid 35205047)
30. Kiplinger GF, Manno JE. Dose-response relationships to cannabis in human subjects. Pharmacol Rev 1971; 23:339-347.
31. P etronis KR, Anthony JC. An epidemiologic investigation of marijuana- and cocaine-related palpitations. Drug Alcohol Depend 1989; 23:219-226. (Pubitemid 19148665)
32. Aryana A, Williams MA. Marijuana as a trigger of cardiovascular events: Speculation or scientifi c certainty? Int J Cardiol 2007; 118:141-144. (Pubitemid 46601644)
33. Adams IB, Martin BR. Cannabis: Pharmacology and toxicology in animals and humans. Addiction 1996; 91:1585-1614. (Pubitemid 26393422)
34. Chimalakonda KC, Bratton SM, Le VH, Yiew KH, Dineva A, Moran CL, et al. Conjugation of Synthetic Cannabinoids, JWH-018 [Naphthalen-1-yl-(1-pentylindol- 3-yl)methanone] and JWH-073 [naphthalen-1-yl-(1-butylindol-3-yl)methanone], Metabolites by Human UDP-glucuronosyltransferases Drug Metab Dispos 2011 Jul 11. [Epub ahead of print].
35. Moran CL, Le VH, Chimalakonda KC, Smedley AL, Lackey FD, Owen SN,et al. Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine. Anal Chem 2011; 1;83:4228-4236.
36. Chimalakonda KC, Moran CL, Kennedy PD, Endres GW, Uzieblo A, Dobrowolski PJ, et al. Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine. Anal Chem 2011; 83:6381-8. [Epub 2010 Apr 28].